Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Telemedicine (Telepathology) Companies
PathAI

Finance & Acquisitions: PathAI

Parents

2017: An $11 million series A round in November 2017 had brought on Pillar Companies, Refactor Capital, 8VC, Danhua Capital and KdT Ventures as investors
2019: PathAI raises $60M for deep learning-based pathology programs
2019: The series B round was led by PathAI’s new backer General Atlantic, alongside participation from General Catalyst
2021: PathAI finds its way to $165M series C for diagnostic and drug development software
Series C financing co-led by D1 Capital Partners and Kaiser Permanente. Additional support came from General Atlantic, Tiger Global Management, 8VC, Adage, Biospring Partners, General Catalyst, KdT Ventures, Polaris Partners, Refactor Capital and several of PathAI’s strategic partners including Bristol-Myers Squibb, Labcorp and Merck through its Global Health Innovation Fund.